[Observation of the impact of nutritional support with beta-hydroxy-beta-methylbutyrate on lean mass parameters of body composition in patients with obesity, type 2 diabetes mellitus and metabolically associated fatty liver disease]
Orvosi Hetilap
- Beta-hydroxy-beta-methylbutyrate
- Type 2 diabetes
- Metabolic dysfunction-associated steatotic liver disease
- Sarcopenic obesity
- Alkaline phosphatase
- Humans
The paper
Fraenkel E, Koky T, Lazúrová I
Orvosi Hetilap · 20 Sep 2026

